Sebastian Trousil is a co-founder and chief operating officer of City Therapeutics. As head of corporate operations, business development and finance, he is enabling the organization to achieve the full impact of our RNAi technology.

Prior to City, Dr. Trousil worked at RTW Investments and Flagship Pioneering, where he led multiple company creation efforts at both firms. He is a co-founder of Harbinger Health, a liquid biopsy company for early cancer detection, which he led from initiation to early proof of concept. 

Dr. Trousil received a master’s degree in pharmacy from the University of Vienna and a Ph.D. from Imperial College London. He conducted postdoctoral research at Harvard Medical School and Massachusetts General Hospital, where he received the prestigious MGH Tosteson Fellowship.